Impact Journals News
Latest Posts
Aging
Behavioral, Morphological and Transcriptomic Changes in a Tauopathy Mouse Model
“Here we used the PS19 (P301S) mouse model of tauopathies to characterize longitudinal changes in behavioral, morphological, and transcriptomic levels.” BUFFALO, NY- November 15, 2023 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed…
Alcohol Consumption and Epigenetic Age Acceleration Across Human Adulthood
“Our findings may help to understand the role of alcohol-associated biological aging in the development of age-related diseases such as CVD and cancer.” BUFFALO, NY- November 14, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed…
A New Connection Between The Gut Microbiota and Prostate Inflammation in Aging Men
“Creating a properly functioning intestinal microenvironment can significantly reduce the overall inflammation, which also affects the prostate.” BUFFALO, NY- November 8, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US”…
ONCOTARGET
Obesity Paradox and Lung Cancer, Metformin-based Therapeutic Opportunity?
“These findings suggest a strong sensitization by the addition of metformin in obese population, suggesting that biochemical and molecular differences influence the treatment response.” BUFFALO, NY- November 15, 2023 – A new editorial paper was published in Oncotarget’s Volume 14…
C/EBPβ Cooperates With MYB to Maintain the Oncogenic Program of AML Cells
“This makes C/EBPβ an interesting pro-oncogenic player in AML, worthy of further studies.” BUFFALO, NY- November 13, 2023 – A new editorial perspective was published in Oncotarget’s Volume 14 on March 11, 2023, entitled, “C/EBPβ cooperates with MYB to maintain…
Combined Inhibition of SHP2 and Mutated RTKs Prevent Acquired Resistance in Leukemia
“In summary, this study reveals a molecular escape mechanism of mutated RTK-driven leukemic cells from SHP2 allosteric inhibition […]” BUFFALO, NY- November 8, 2023 – A new editorial paper was published in Oncotarget’s Volume 14 on March 31, 2023, entitled,…
VIEW MORE ONCOTARGET ARTICLES ➜
ONCOSCIENCE
DDX53: A Potential Early Esophageal Cancer Antigen
“In this ESCA study, the possibility of an immune response that selected for tumor cells lacking the DDX53 CTA is discussed.” BUFFALO, NY- November 17, 2023 – A new research paper was published in Oncoscience (Volume 10) on November 10,…
Management of Recurrent Gastrointestinal Cancer with Ripretinib and Surgery
“The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.” BUFFALO, NY- November 3, 2023 – A new case report was published in Oncoscience (Volume 10) on September…
Diagnosis and Management of Postoperative Wound Infections in the Head and Neck Region
“The majority of wound infections often manifest themselves immediately postoperatively, so close followup should take place […]” BUFFALO, NY- October 20, 2023 – A new research perspective was published in Oncoscience (Volume 10) on October 4, 2023, entitled, “Diagnosis and…
VIEW MORE ONCOSCIENCE ARTICLES ➜
GENES & CANCER
Increased BRD4-L and BRD4-S Promotes Chemotherapy Resistance in Ovarian Carcinoma
“Overall, our work revealed a strong positive correlation between BRD4 overexpression status and chemoresistance in ovarian cancer […]” BUFFALO, NY- September 13, 2023 – A new research paper was published in Genes & Cancer on September 12, 2023, entitled, “Increased…
A Novel Chromosomal Abnormality in AML Patient: Case Report and Literature Review
“Here we report an unusual association of t (5; 17) with t (8; 21) in AML and we try to discuss the prognosis of this association and then the treatment.” BUFFALO, NY- July 7, 2023 – A new research paper…
Genes & Cancer | VCP/p97 as a Therapeutic Target in KRAS-Mutant Pancreatic Cancer
“In summary, our goal was to identify additional therapeutic targets for KRAS-driven PDAC.” Listen to an audio version of this press release BUFFALO, NY- March 24, 2023 – A new research paper was published in Genes & Cancer on March…
VIEW MORE GENES & CANCER ARTICLES ➜
NEWS
Ride for Roswell 2023: Team Open Access Recap
In a remarkable achievement, Impact Journals and Team Open Access contributed to an impressive total raise of $5.6 million (and the amount continues to grow) for cancer research through the Ride for Roswell. This outstanding outcome is a testament to…
Impact Journals Sponsors 2023 Ride for Roswell
Impact Journals is sponsoring Team Open Access in the annual cycling event to end cancer: The Ride for Roswell. This fundraiser is hosted by Roswell Park Comprehensive Cancer Center in Buffalo, New York. — BUFFALO, NY- June 19, 2023 –…
Impact Journals at SSP 45th Annual Meeting
Impact Journals is proud to participate at the Society for Scholarly Publishing (SSP) 45th Annual Meeting, which convenes May 31–June 2, 2023, in Portland, Oregon. Listen to an audio version of this press release BUFFALO, NY-May 17, 2023 – Impact…